Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

4 results found
There are 3 active filters
Clear all filters
Eswatini
Uganda
antiretroviral medicines

4 results found

MSF Expert Client performing a HIV test at the MSF Dipping Tank community testing campaign at Nhletsheni, in Shiselweleni region, south of Swaziland.

Press release |

20 July 2015

MSF response to START trial data showing all people with HIV should be treated immediately

Tags HIV/AIDS HIV/AIDS antiretroviral medicines International AIDS Conference Eswatini

MSF Staff addressing the community during the Dip Tank community testing campaign at Nhletsheni, in Shiselweleni region, south of Swaziland.

Feature story |

27 November 2012

Swaziland: Trying out new approaches to HIV treatment

Tags HIV/AIDSIntellectual property and trade antiretroviral medicines diagnostic tests World AIDS Day Eswatini

Opinion article |

01 December 2011

Going backwards on the fight against Aids: What to tell the patients?

Tags HIV/AIDS HIV/AIDS antiretroviral medicines Eswatini

Research article |

27 July 2011

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

Tags HIV/AIDS HIV/AIDS antiretroviral medicines Uganda